Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adaptimmune Therapeutics plc    ADAP

ADAPTIMMUNE THERAPEUTICS PLC

(ADAP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about ADAPTIMMUNE THERAPEUTICS P
02/20ADAPTIMMUNE THERAPEUTICS : to Report Full Year / Q4 2019 Financial Results and B..
AQ
02/18Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
GL
02/10ADAPTIMMUNE THERAPEUTICS : Announces Full Exercise and Closing of Underwriters' ..
AQ
02/07Adaptimmune Therapeutics plc Announces Full Exercise and Closing of Underwrit..
GL
01/27ADAPTIMMUNE THERAPEUTICS : Announces Closing of Public Offering of American Depo..
AQ
01/24Adaptimmune Therapeutics plc Announces Closing of Public Offering of American..
GL
01/22Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Sh..
GL
01/21Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary ..
GL
01/14Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercial..
GL
01/13Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes ..
GL
01/13Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses i..
GL
2019ADAPTIMMUNE THERAPEUTICS : Regenerative Medicine Advanced Therapy Designation Gr..
AQ
2019Regenerative Medicine Advanced Therapy Designation Granted by FDA to ADP̴..
GL
2019ADAPTIMMUNE THERAPEUTICS : Updated Data from Phase 1 ADP-A2M4 Trial Demonstratin..
AQ
2019Updated Data from Phase 1 ADP-A2M4 Trial Demonstrating Continued Clinical Ben..
GL
More most relevant news
All news about ADAPTIMMUNE THERAPEUTICS P
02/20ADAPTIMMUNE THERAPEUTICS : to Report Full Year / Q4 2019 Financial Results and B..
AQ
02/18ADAPTIMMUNE THERAPEUTICS PLC : Change in Directors or Principal Officers, Other ..
AQ
02/18Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
GL
02/10ADAPTIMMUNE THERAPEUTICS : Announces Full Exercise and Closing of Underwriters' ..
AQ
02/07ADAPTIMMUNE THERAPEUTICS PLC : Other Events, Financial Statements and Exhibits (..
AQ
02/07Adaptimmune Therapeutics plc Announces Full Exercise and Closing of Underwrit..
GL
01/27ADAPTIMMUNE THERAPEUTICS : Announces Closing of Public Offering of American Depo..
AQ
01/24Adaptimmune Therapeutics plc Announces Closing of Public Offering of American..
GL
01/22ADAPTIMMUNE THERAPEUTICS PLC : Entry into a Material Definitive Agreement, Other..
AQ
01/22Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Sh..
GL
More news
News in other languages on ADAPTIMMUNE THERAPEUTICS P

- No features available -

Press releases
02/20ADAPTIMMUNE THERAPEUTICS : to Report Full Year / Q4 2019 Financial Results and B..
AQ
02/18ADAPTIMMUNE THERAPEUTICS PLC : Change in Directors or Principal Officers, Other ..
AQ
02/18Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
GL
02/10ADAPTIMMUNE THERAPEUTICS : Announces Full Exercise and Closing of Underwriters' ..
AQ
02/07ADAPTIMMUNE THERAPEUTICS PLC : Other Events, Financial Statements and Exhibits (..
AQ
More press releases
Sector news : Bio Therapeutic Drugs
02/20Anglo American Discloses All Mine Deaths in Industry Shift--Update
DJ
02/20Anglo American Discloses All Mine Deaths in Industry Shift -- Update
DJ
02/20Anglo American Discloses All Mine Deaths in Industry Shift
DJ
02/20GlaxoSmithKline Invests $50 Million in Biotech Startup's Cell-Therapy Program
DJ
02/19Five Prime Therapeutics In License Agreement with Seattle Genetics
DJ
More sector news : Bio Therapeutic Drugs
Upcoming event on ADAPTIMMUNE THERAPEUTICS P